A Phase 1/1b/2a, 3-Part, Open-Label, Multicentre Study To Assess The Safety, Tolerability, Pharmacokinetics And Preliminary Antitumor Activity Of Ascending Doses Of AZD5991 In Subjects With Relapsed Or Refractory Haematologic Malignancies Read more
Astrazeneca/ Treatment Patterns, Outcomes, And Patient-Reported Health-Related Quality Of Life: A Prospective Disease Registry Of Patients With Mantle Cell Lymphoma Treated With Novel Agents Read more
An Open-Label, Multicenter, Phase I Trial Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of BTCT4465A In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin?S Lymphoma And Chronic Lymphocytic Leukemia Read more
Phase I/II Of Nivolumab And A(B)VD In The Front-Line Setting For High Risk Hodgkin Lymphoma Read more
A Phase II Trial Of PET-Directed Therapy Using AVD (Doxorubicin, Vinblastine, And Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, With Or Without Brentuximab Vedotin Plus Nivolumab, Followed By Nivolumab Consolidation For Patients With Previously Untreated Non-Bulky Limited Stage Hodgkin Lymphoma Read more
An Open Label, Compassionate Use Study Of Tenalisib (RP6530) In Patients Currently Receiving Treatment On Tenalisib Trials In Hematological Malignancies Read more
